Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells

BACKGROUND: The use of glucose as the only osmotic agent in peritoneal dialysis (PD) solutions (PDSs) is believed to exert local (peritoneal) and systemic detrimental actions, particularly in diabetic PD patients. To improve peritoneal biocompatibility, we have developed more biocompatible PDSs cont...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Drug Des Devel Ther
Asıl Yazarlar: Bonomini, Mario, Di Silvestre, Sara, Di Tomo, Pamela, Di Pietro, Natalia, Mandatori, Domitilla, Di Liberato, Lorenzo, Sirolli, Vittorio, Chiarelli, Francesco, Indiveri, Cesare, Pandolfi, Assunta, Arduini, Arduino
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2016
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5135076/
https://ncbi.nlm.nih.gov/pubmed/27932866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S117078
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller